Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02340689 · ClinicalTrials.gov registry record
Primary Hyperoxaluria Mutation Genotyping/Phenotyping
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 1,235
- Enrollment target
NCT02340689: Completed study, sponsored by Mayo Clinic.
NCT02340689 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 1,235 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02340689 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 1,235 participants
- Enrollment target
Study Summary
Specific mutations relating to hyperoxaluria will be determined via DNA analysis by the Mayo RKSC research staff.
Primary Outcome
Correlation of genotype with severity of disease as defined by age at onset of symptoms
Interventions
- OTHER Genetic Analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,235 participants |
| Start Date | 2013-10 |
| Est. Completion | 2018-12 |
What the finished NCT02340689 record still lists
NCT02340689 is an observational study that tracks outcomes without assigning an intervention. Its 1,235 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Genetic Analysis is the first listed.
NCT02340689 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02340689 about?
NCT02340689 is a clinical study titled "Primary Hyperoxaluria Mutation Genotyping/Phenotyping". Specific mutations relating to hyperoxaluria will be determined via DNA analysis by the Mayo RKSC research staff.
What is the current status of trial NCT02340689?
This trial is currently completed. The enrollment target is 1,235 participants. The study started on 2013-10. Estimated completion is 2018-12.
What interventions are being tested in trial NCT02340689?
The interventions under investigation include: Genetic Analysis (OTHER).
Who is sponsoring clinical trial NCT02340689?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05456841 · 1,232 participants · NA
Empathic Communication Skills (ECS) Training
- NCT05946044 · 1,230 participants · NA
The Osteoarthritis Prevention Study
- NCT06787937 · 1,230 participants · NA
Communicating About Nicotine Reduction in Cigarettes
- NCT06368245 · 1,244 participants
Durability of Suppl. Rod Constructs-SuppleMentAry Rod Technique for Long-segment Posterior Instrumented Spinal Fusions
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia